Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda

Authors: Sara Bennett, Ligia Paina, Freddie Ssengooba, Douglas Waswa, James M M’Imunya

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

The Fogarty International Center (FIC) has supported research capacity development for over twenty years. While the mission of FIC is supporting and facilitating global health research conducted by U.S. and international investigators, building partnerships between health research institutions in the U.S. and abroad, and training the next generation of scientists to address global health needs, research capacity may impact health policies and programs and therefore have positive impacts on public health. We conducted an exploratory analysis of how FIC research training investments affected public health policy and program development in Kenya and Uganda.

Methods

We explored the long term impacts of all FIC supported research training programs using case studies, in Kenya and Uganda. Semi-structured in-depth interviews were conducted with 53 respondents and 29 focus group discussion participants across the two countries. Qualitative methods were supplemented by structured surveys of trainees and document review, including a review of evidence cited in policy documents.

Results

In the primary focal areas of FIC grants, notably HIV/AIDS, there were numerous examples of work conducted by former FIC trainees that influenced national and global policies. Facilitators for this influence included the strong technical skills and scientific reputations of the trainees, and professional networks spanning research and policy communities. Barriers included the fact that trainees typically had not received training in research communication, relatively few policy makers had received scientific training, and institutional constraints that undermined alignment of research with policy needs.

Conclusions

While FIC has not focused its programs on the goal of policy and program influence, its investments have affected global and national public health policies and practice. These influences have occurred primarily through strengthening research skills of scientists and developing strong in-country networks. Further success of FIC and similar initiatives could be stimulated by investing more in the training of policy-makers, seeking to better align research with policy needs through more grants that are awarded directly to developing country institutions, and grants that better incorporate policy maker perspectives in their design and governance. Addressing structural constraints, for example supporting the development of national research agendas that inform university research, would further support such efforts.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Marjanovic S, et al: Research capacity building in Africa: networks, institutions and local ownership. J Int Dev. 2012, doi:10.1002/jid.2870 Marjanovic S, et al: Research capacity building in Africa: networks, institutions and local ownership. J Int Dev. 2012, doi:10.1002/jid.2870
3.
go back to reference DFID: DFID Research Strategy: 2008–2013. 2008, DFID: London DFID: DFID Research Strategy: 2008–2013. 2008, DFID: London
4.
go back to reference Nchinda TC: Research capacity strengthening in the South. Soc Sci Med. 2002, 54 (11): 1699-1711. 10.1016/S0277-9536(01)00338-0.CrossRefPubMed Nchinda TC: Research capacity strengthening in the South. Soc Sci Med. 2002, 54 (11): 1699-1711. 10.1016/S0277-9536(01)00338-0.CrossRefPubMed
5.
go back to reference Gadsby EW: Research capacity strengthening: donor approaches to improving and assessing its impact in low- and middle-income countries. Int J Health Plann Manage. 2011, 26 (1): 89-106. 10.1002/hpm.1031.CrossRefPubMed Gadsby EW: Research capacity strengthening: donor approaches to improving and assessing its impact in low- and middle-income countries. Int J Health Plann Manage. 2011, 26 (1): 89-106. 10.1002/hpm.1031.CrossRefPubMed
6.
go back to reference Minja H, et al: Impact of health research capacity strengthening in low- and middle-income countries: the case of WHO/TDR programmes. PLoS Negl Trop Dis. 2011, 5 (10): e1351-10.1371/journal.pntd.0001351. doi:10.1371/journal.pntd.0001351CrossRefPubMedPubMedCentral Minja H, et al: Impact of health research capacity strengthening in low- and middle-income countries: the case of WHO/TDR programmes. PLoS Negl Trop Dis. 2011, 5 (10): e1351-10.1371/journal.pntd.0001351. doi:10.1371/journal.pntd.0001351CrossRefPubMedPubMedCentral
7.
go back to reference Bremen J, et al: Global health: the Fogarty International Center, National Institutes of Health: vision and Mission, Programs and Accomplishments. Infect Dis Clin North Am. 2011, 25 (3): 311-336. doi:10.1016/j.idc.2011.06.003 Bremen J, et al: Global health: the Fogarty International Center, National Institutes of Health: vision and Mission, Programs and Accomplishments. Infect Dis Clin North Am. 2011, 25 (3): 311-336. doi:10.1016/j.idc.2011.06.003
8.
go back to reference Fauci AS, Folkers GK: Investing to meet the scientific challenges of HIV/AIDS. Health Aff (Millwood). 2009, 28 (6): 1629-1641. 10.1377/hlthaff.28.6.1629.CrossRef Fauci AS, Folkers GK: Investing to meet the scientific challenges of HIV/AIDS. Health Aff (Millwood). 2009, 28 (6): 1629-1641. 10.1377/hlthaff.28.6.1629.CrossRef
9.
go back to reference Mitton C, et al: Knowledge transfer and exchange: review and synthesis of the literature. Milbank Q. 2007, 85 (4): 729-768. 10.1111/j.1468-0009.2007.00506.x.CrossRefPubMedPubMedCentral Mitton C, et al: Knowledge transfer and exchange: review and synthesis of the literature. Milbank Q. 2007, 85 (4): 729-768. 10.1111/j.1468-0009.2007.00506.x.CrossRefPubMedPubMedCentral
10.
go back to reference Kok MO, Schuit AJ: Contribution mapping: a method for mapping the contribution of research to enhance its impact. Health Res Policy Syst. 2012, 10: 21-10.1186/1478-4505-10-21.CrossRefPubMedPubMedCentral Kok MO, Schuit AJ: Contribution mapping: a method for mapping the contribution of research to enhance its impact. Health Res Policy Syst. 2012, 10: 21-10.1186/1478-4505-10-21.CrossRefPubMedPubMedCentral
11.
go back to reference Wooding S, et al: Payback arising from research funding: evaluation of the Arthritis Research Campaign. Rheumatology (Oxford). 2005, 44 (9): 1145-1156. 10.1093/rheumatology/keh708.CrossRef Wooding S, et al: Payback arising from research funding: evaluation of the Arthritis Research Campaign. Rheumatology (Oxford). 2005, 44 (9): 1145-1156. 10.1093/rheumatology/keh708.CrossRef
12.
go back to reference Trostle J: Research capacity building in international health: definitions, evaluations and strategies for success. Soc Sci Med. 1992, 35 (11): 1321-1324. 10.1016/0277-9536(92)90035-O.CrossRefPubMed Trostle J: Research capacity building in international health: definitions, evaluations and strategies for success. Soc Sci Med. 1992, 35 (11): 1321-1324. 10.1016/0277-9536(92)90035-O.CrossRefPubMed
13.
go back to reference Gerring J: Case study research: Principles and practice. 2007, Cambridge: Cambridge University Press Gerring J: Case study research: Principles and practice. 2007, Cambridge: Cambridge University Press
14.
go back to reference Musoke P, et al: A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS. 1999, 13 (4): 479-486. 10.1097/00002030-199903110-00006.CrossRefPubMed Musoke P, et al: A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS. 1999, 13 (4): 479-486. 10.1097/00002030-199903110-00006.CrossRefPubMed
15.
go back to reference Guay LA, et al: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999, 354 (9181): 795-802. 10.1016/S0140-6736(99)80008-7.CrossRefPubMed Guay LA, et al: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999, 354 (9181): 795-802. 10.1016/S0140-6736(99)80008-7.CrossRefPubMed
16.
go back to reference Jackson JB, et al: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003, 362 (9387): 859-868. 10.1016/S0140-6736(03)14341-3.CrossRefPubMed Jackson JB, et al: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003, 362 (9387): 859-868. 10.1016/S0140-6736(03)14341-3.CrossRefPubMed
18.
go back to reference Gray RH, et al: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007, 369 (9562): 657-666. 10.1016/S0140-6736(07)60313-4.CrossRefPubMed Gray RH, et al: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007, 369 (9562): 657-666. 10.1016/S0140-6736(07)60313-4.CrossRefPubMed
19.
go back to reference Adatu F, et al: Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998–1999. Int J Tuberc Lung Dis. 2003, 7 (9 Suppl 1): S63-S71.PubMed Adatu F, et al: Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998–1999. Int J Tuberc Lung Dis. 2003, 7 (9 Suppl 1): S63-S71.PubMed
20.
go back to reference Mafigiri DK, McGrath JW, Whalen CC: Task shifting for tuberculosis control: a qualitative study of community-based directly observed therapy in urban Uganda. Glob Public Health. 2012, 7 (3): 270-84. 10.1080/17441692.2011.552067. doi:10.1080/17441692.2011.552067CrossRefPubMed Mafigiri DK, McGrath JW, Whalen CC: Task shifting for tuberculosis control: a qualitative study of community-based directly observed therapy in urban Uganda. Glob Public Health. 2012, 7 (3): 270-84. 10.1080/17441692.2011.552067. doi:10.1080/17441692.2011.552067CrossRefPubMed
21.
go back to reference Katamba A, Laticevschi D, Rieder HL: Efficiency of a third serial sputum smear examination in the diagnosis of tuberculosis in Moldova and Uganda. Int J Tuberc Lung Dis. 2007, 11 (6): 659-664.PubMed Katamba A, Laticevschi D, Rieder HL: Efficiency of a third serial sputum smear examination in the diagnosis of tuberculosis in Moldova and Uganda. Int J Tuberc Lung Dis. 2007, 11 (6): 659-664.PubMed
22.
go back to reference Namagembe I, et al: Consumption of alcoholic beverages among pregnant urban Ugandan women. Matern Child Health J. 2010, 14 (4): 492-500. 10.1007/s10995-009-0500-3.CrossRefPubMed Namagembe I, et al: Consumption of alcoholic beverages among pregnant urban Ugandan women. Matern Child Health J. 2010, 14 (4): 492-500. 10.1007/s10995-009-0500-3.CrossRefPubMed
24.
go back to reference Rousseau CM, et al: Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis. 2004, 190 (10): 1880-1888. 10.1086/425076.CrossRefPubMedPubMedCentral Rousseau CM, et al: Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis. 2004, 190 (10): 1880-1888. 10.1086/425076.CrossRefPubMedPubMedCentral
25.
go back to reference Nduati R, et al: Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000, 283 (9): 1167-1174. 10.1001/jama.283.9.1167.CrossRefPubMed Nduati R, et al: Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000, 283 (9): 1167-1174. 10.1001/jama.283.9.1167.CrossRefPubMed
26.
go back to reference Nduati R, et al: Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet. 2001, 357 (9269): 1651-1655. 10.1016/S0140-6736(00)04820-0.CrossRefPubMedPubMedCentral Nduati R, et al: Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet. 2001, 357 (9269): 1651-1655. 10.1016/S0140-6736(00)04820-0.CrossRefPubMedPubMedCentral
27.
go back to reference Otieno PA, et al: HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. J Infect Dis. 2007, 195 (2): 220-229. 10.1086/510245.CrossRefPubMed Otieno PA, et al: HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. J Infect Dis. 2007, 195 (2): 220-229. 10.1086/510245.CrossRefPubMed
28.
go back to reference Kiarie JN, et al: Infant feeding practices of women in a perinatal HIV-1 prevention study in Nairobi, Kenya. J Acquir Immune Defic Syndr. 2004, 35 (1): 75-81. 10.1097/00126334-200401010-00011.CrossRefPubMedPubMedCentral Kiarie JN, et al: Infant feeding practices of women in a perinatal HIV-1 prevention study in Nairobi, Kenya. J Acquir Immune Defic Syndr. 2004, 35 (1): 75-81. 10.1097/00126334-200401010-00011.CrossRefPubMedPubMedCentral
29.
go back to reference Mbori-Ngacha D, et al: Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA. 2001, 286 (19): 2413-2420. 10.1001/jama.286.19.2413.CrossRefPubMedPubMedCentral Mbori-Ngacha D, et al: Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA. 2001, 286 (19): 2413-2420. 10.1001/jama.286.19.2413.CrossRefPubMedPubMedCentral
30.
go back to reference Cherutich P, et al: Optimizing paediatric HIV care in Kenya: challenges in early infant diagnosis. Bull World Health Organ. 2008, 86 (2): 155-160. 10.2471/BLT.07.040402.CrossRefPubMed Cherutich P, et al: Optimizing paediatric HIV care in Kenya: challenges in early infant diagnosis. Bull World Health Organ. 2008, 86 (2): 155-160. 10.2471/BLT.07.040402.CrossRefPubMed
31.
go back to reference Inwani I, et al: Performance of clinical algorithms for HIV-1 diagnosis and antiretroviral initiation among HIV-1-exposed children aged less than 18 months in Kenya. J Acquir Immune Defic Syndr. 2009, 50 (5): 492-498. 10.1097/QAI.0b013e318198a8a4.CrossRefPubMedPubMedCentral Inwani I, et al: Performance of clinical algorithms for HIV-1 diagnosis and antiretroviral initiation among HIV-1-exposed children aged less than 18 months in Kenya. J Acquir Immune Defic Syndr. 2009, 50 (5): 492-498. 10.1097/QAI.0b013e318198a8a4.CrossRefPubMedPubMedCentral
32.
go back to reference Lingappa JR, et al: Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One. 2009, 4 (4): e5272-10.1371/journal.pone.0005272.CrossRefPubMedPubMedCentral Lingappa JR, et al: Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One. 2009, 4 (4): e5272-10.1371/journal.pone.0005272.CrossRefPubMedPubMedCentral
33.
go back to reference Lingappa JR, et al: Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One. 2008, 3 (1): e1411-10.1371/journal.pone.0001411.CrossRefPubMedPubMedCentral Lingappa JR, et al: Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One. 2008, 3 (1): e1411-10.1371/journal.pone.0001411.CrossRefPubMedPubMedCentral
34.
35.
go back to reference Richardson BA, et al: Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis. 2001, 28 (7): 394-400. 10.1097/00007435-200107000-00006.CrossRefPubMed Richardson BA, et al: Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis. 2001, 28 (7): 394-400. 10.1097/00007435-200107000-00006.CrossRefPubMed
36.
go back to reference Kaul R, et al: Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA. 2004, 291 (21): 2555-2562. 10.1001/jama.291.21.2555.CrossRefPubMed Kaul R, et al: Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA. 2004, 291 (21): 2555-2562. 10.1001/jama.291.21.2555.CrossRefPubMed
37.
go back to reference Kaul R, et al: Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis. 2007, 196 (11): 1692-1697. 10.1086/522006.CrossRefPubMed Kaul R, et al: Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis. 2007, 196 (11): 1692-1697. 10.1086/522006.CrossRefPubMed
38.
go back to reference Moses S, et al: Response of a sexually transmitted infection epidemic to a treatment and prevention programme in Nairobi, Kenya. Sex Transm Infect. 2002, 78 (Suppl 1): i114-i120.CrossRefPubMedPubMedCentral Moses S, et al: Response of a sexually transmitted infection epidemic to a treatment and prevention programme in Nairobi, Kenya. Sex Transm Infect. 2002, 78 (Suppl 1): i114-i120.CrossRefPubMedPubMedCentral
39.
go back to reference Voeten HA, et al: Quality of sexually transmitted disease case management in Nairobi, Kenya: a comparison among different types of healthcare facilities. Sex Transm Dis. 2001, 28 (11): 633-642. 10.1097/00007435-200111000-00005.CrossRefPubMed Voeten HA, et al: Quality of sexually transmitted disease case management in Nairobi, Kenya: a comparison among different types of healthcare facilities. Sex Transm Dis. 2001, 28 (11): 633-642. 10.1097/00007435-200111000-00005.CrossRefPubMed
40.
go back to reference Haas PM: Epistemic Communities and International-Policy Coordination - Introduction. Int Organ. 1992, 46 (1): 1-35. 10.1017/S0020818300001442.CrossRef Haas PM: Epistemic Communities and International-Policy Coordination - Introduction. Int Organ. 1992, 46 (1): 1-35. 10.1017/S0020818300001442.CrossRef
41.
go back to reference Innvaer S, et al: Health policy-makers perception of their use of evidence: a systematic review. J Health Serv Res Pol. 2002, 7 (4): 239-244. 10.1258/135581902320432778.CrossRef Innvaer S, et al: Health policy-makers perception of their use of evidence: a systematic review. J Health Serv Res Pol. 2002, 7 (4): 239-244. 10.1258/135581902320432778.CrossRef
42.
go back to reference Hyder AA, et al: National policy-makers speak out: are researchers giving them what they need?. Health Policy Plan. 2011, 26 (1): 73-82. 10.1093/heapol/czq020.CrossRefPubMed Hyder AA, et al: National policy-makers speak out: are researchers giving them what they need?. Health Policy Plan. 2011, 26 (1): 73-82. 10.1093/heapol/czq020.CrossRefPubMed
43.
go back to reference van Kammen J, de Savigny D, Sewankambo N: Using knowledge brokering to promote evidence-based policy-making: the need for support structures. Bull World Health Organ. 2006, 84 (8): 608-612. 10.2471/BLT.05.028308.CrossRefPubMedPubMedCentral van Kammen J, de Savigny D, Sewankambo N: Using knowledge brokering to promote evidence-based policy-making: the need for support structures. Bull World Health Organ. 2006, 84 (8): 608-612. 10.2471/BLT.05.028308.CrossRefPubMedPubMedCentral
44.
45.
go back to reference Ortiz A, Taylor P: Learning Purposefully in Capacity Development. Why, what and when to measure?. 2009, Paris: UNESCO, 1-49. Ortiz A, Taylor P: Learning Purposefully in Capacity Development. Why, what and when to measure?. 2009, Paris: UNESCO, 1-49.
46.
go back to reference Bornmann L: What is the societal impact of resaerch and how can it be assessed? A literature survey. J Am Soc Inf Sci Technol. 2013, 64 (2): 217-233. 10.1002/asi.22803.CrossRef Bornmann L: What is the societal impact of resaerch and how can it be assessed? A literature survey. J Am Soc Inf Sci Technol. 2013, 64 (2): 217-233. 10.1002/asi.22803.CrossRef
Metadata
Title
The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda
Authors
Sara Bennett
Ligia Paina
Freddie Ssengooba
Douglas Waswa
James M M’Imunya
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-770

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue